Abcellera Biologics Inc ABCL

$10.47 -0.55 (-4.99%)

Valuation

Market cap
3,602,597,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
2,489,600
Avg volume
4,314,514
Day's range
$10.38 – $11.29
Shares out
326,618,000
Stochastic %K
10%
Beta
1.59
Analysts
Strong Buy
Price target
$18.58

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

GridironGainz Nov 19, 10:47 PM 0 replies
PLTRLONGDONG Nov 19, 10:46 PM
$ABCL i didnt plan to buy more because this is 30% of my portfolio but sub $10 i wouldnt be able to pass that up
0 replies
Vextra Nov 19, 9:13 PM
Look at ticker FGI spiking now. crazy! If you want to be early for once look at FGI 🚀 FGI is just starting lets hope it pulls a OMH 2,000% type of run!! FGI on watch from $ABCL $FBIO $SNDX CC
0 replies
Buying_Low_Selling_High Nov 19, 9:11 PM
$ABCL The day to forget. Nothing to worry though, the fact is we have the drug, rest will happen in due time.
0 replies
GridironGainz Nov 19, 8:32 PM 0 replies
flymetothemoon2 Nov 19, 7:47 PM
$ABCL Being able to buy $1.00 lower than both CARL CEO and Andrew both bought @11.54. $750,000 and $125,000 respectively. What a BLESSING… 🙏!!
0 replies
flymetothemoon2 Nov 19, 7:39 PM
$ABCL NO BRAINER!!! $ABCL bought more! Thanks ANT!!!!
0 replies
Buying_Low_Selling_High Nov 19, 7:38 PM
$ABCL very low volume today but big big mistake selling this today (or in fact below 12$).
0 replies